Unlocking the Mechanisms of Cutaneous Adverse Drug Reactions: Activation of the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway by EGFR Inhibitors Triggers Keratinocyte Differentiation and Polarization of Epidermal Immune Responses

EGFR inhibitors used in oncology therapy modify the keratinocyte differentiation processes, impairing proper skin barrier formation and leading to cutaneous adverse drug reactions. To uncover the molecular signatures associated with cutaneous adverse drug reactions, we applied phosphoproteomic and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ondet, Thomas, Roux, Pierre-François, Monshouwer, Mario, Stamatas, Georgios N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659385/
https://www.ncbi.nlm.nih.gov/pubmed/34909713
http://dx.doi.org/10.1016/j.xjidi.2021.100009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659385/
https://www.ncbi.nlm.nih.gov/pubmed/34909713
http://dx.doi.org/10.1016/j.xjidi.2021.100009

Ejemplares similares